"er positive breast cancer" trang 1 - tải miễn phí từ tailieuXANH
The combination of methylsulfonylmethane and tamoxifen inhibits the Jak2/STAT5b pathway and synergistically inhibits tumor growth and metastasis in ER-positive breast cancer xenografts

The combination of methylsulfonylmethane and tamoxifen inhibits the Jak2/STAT5b pathway and synergistically inhibits tumor growth and metastasis in ER-positive breast cancer xenografts
16    45    0
Functional role of miR-10b in tamoxifen resistance of ER-positive breast cancer cells through down-regulation of HDAC4

Functional role of miR-10b in tamoxifen resistance of ER-positive breast cancer cells through down-regulation of HDAC4
10    41    0
Metformin enhances tamoxifen-mediated tumor growth inhibition in ER-positive breast carcinoma

Metformin enhances tamoxifen-mediated tumor growth inhibition in ER-positive breast carcinoma
11    67    0
Leptin-induced ER-α-positive breast cancer cell viability and migration is mediated by suppressing CCN5-signaling via activating JAK/AKT/STAT-pathway

Leptin-induced ER-α-positive breast cancer cell viability and migration is mediated by suppressing CCN5-signaling via activating JAK/AKT/STAT-pathway
14    82    0
Power of PgR expression as a prognostic factor for ER-positive/HER2-negative breast cancer patients at intermediate risk classified by the Ki67 labeling index

Power of PgR expression as a prognostic factor for ER-positive/HER2-negative breast cancer patients at intermediate risk classified by the Ki67 labeling index
9    82    0
Adjuvant treatment recommendations for patients with ER-positive/HER2-negative early breast cancer by Swiss tumor boards using the 21-gene recurrence score (SAKK 26/10)

Adjuvant treatment recommendations for patients with ER-positive/HER2-negative early breast cancer by Swiss tumor boards using the 21-gene recurrence score (SAKK 26/10)
10    59    0
Palmitate-induced ER stress increases trastuzumab sensitivity in HER2/neupositive breast cancer cells

Palmitate-induced ER stress increases trastuzumab sensitivity in HER2/neupositive breast cancer cells
15    50    0
Induction of proto-oncogene BRF2 in breast cancer cells by the dietary soybean isoflavone daidzein

Induction of proto-oncogene BRF2 in breast cancer cells by the dietary soybean isoflavone daidzein
11    155    2
Expression of calcium pumps is differentially regulated by histone deacetylase inhibitors and estrogen receptor alpha in breast cancer cells

Expression of calcium pumps is differentially regulated by histone deacetylase inhibitors and estrogen receptor alpha in breast cancer cells
17    55    0
Impact of molecular subtypes on the prediction of distant recurrence in estrogen receptor (ER) positive, human epidermal growth factor receptor 2 (HER2) negative breast cancer upon five years of endocrine therapy

Impact of molecular subtypes on the prediction of distant recurrence in estrogen receptor (ER) positive, human epidermal growth factor receptor 2 (HER2) negative breast cancer upon five years of endocrine therapy
9    55    0
Stromal ColXα1 expression correlates with tumor-infiltrating lymphocytes and predicts adjuvant therapy outcome in ER-positive/ HER2-positive breast cancer

Stromal ColXα1 expression correlates with tumor-infiltrating lymphocytes and predicts adjuvant therapy outcome in ER-positive/ HER2-positive breast cancer
8    108    0
FOXA1 and AR in invasive breast cancer: New findings on their co-expression and impact on prognosis in ER-positive patients

FOXA1 and AR in invasive breast cancer: New findings on their co-expression and impact on prognosis in ER-positive patients
9    83    0
Comparisons of tumor-infiltrating lymphocyte levels and the 21-gene recurrence score in ER-positive /HER2-negative breast cancer

Comparisons of tumor-infiltrating lymphocyte levels and the 21-gene recurrence score in ER-positive /HER2-negative breast cancer
9    64    0
Phosphorylation of p90RSK is associated with increased response to neoadjuvant chemotherapy in ER-positive breast cancer

Phosphorylation of p90RSK is associated with increased response to neoadjuvant chemotherapy in ER-positive breast cancer
9    55    0
Stereotactic radiotherapy for oligoprogressive ER-positive breast cancer (AVATAR)

Stereotactic radiotherapy for oligoprogressive ER-positive breast cancer (AVATAR)
9    46    1
Response to neoadjuvant chemotherapy based on pathologic complete response in very young patients with ER-positive breast cancer: A large, multicenter, observational study

Response to neoadjuvant chemotherapy based on pathologic complete response in very young patients with ER-positive breast cancer: A large, multicenter, observational study
11    220    1
Serum soluble ST2 is associated with ER-positive breast cancer

Serum soluble ST2 is associated with ER-positive breast cancer
8    45    0
Reproductive factors and risk of hormone receptor positive and negative breast cancer: A cohort study

Reproductive factors and risk of hormone receptor positive and negative breast cancer: A cohort study
12    76    0
Neoadjuvant everolimus plus letrozole versus fluorouracil, epirubicin and cyclophosphamide for ER-positive, HER2- negative breast cancer: A randomized pilot trial

Neoadjuvant everolimus plus letrozole versus fluorouracil, epirubicin and cyclophosphamide for ER-positive, HER2- negative breast cancer: A randomized pilot trial
12    36    1
Re-wiring and gene expression changes of AC025034.1 and ATP2B1 play complex roles in early-to-late breast cancer progression

Re-wiring and gene expression changes of AC025034.1 and ATP2B1 play complex roles in early-to-late breast cancer progression
15    8    1
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.